These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 30472943)

  • 1. Pluripotent Stem Cells for Modelling and Cell Therapy of Parkinson's Disease.
    Lebedeva OS; Lagarkova MA
    Biochemistry (Mosc); 2018 Sep; 83(9):1046-1056. PubMed ID: 30472943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.
    Momcilovic O; Sivapatham R; Oron TR; Meyer M; Mooney S; Rao MS; Zeng X
    PLoS One; 2016; 11(5):e0154890. PubMed ID: 27191603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons.
    Schwab AJ; Sison SL; Meade MR; Broniowska KA; Corbett JA; Ebert AD
    Stem Cell Reports; 2017 Dec; 9(6):1839-1852. PubMed ID: 29129681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced dopaminergic neurons: A new promise for Parkinson's disease.
    Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
    Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
    Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects.
    Borgs L; Peyre E; Alix P; Hanon K; Grobarczyk B; Godin JD; Purnelle A; Krusy N; Maquet P; Lefebvre P; Seutin V; Malgrange B; Nguyen L
    Sci Rep; 2016 Sep; 6():33377. PubMed ID: 27640816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges.
    Xiao B; Ng HH; Takahashi R; Tan EK
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):697-702. PubMed ID: 26833176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
    Stoddard-Bennett T; Reijo Pera R
    Cells; 2019 Jan; 8(1):. PubMed ID: 30621042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J; Barker RA
    Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficient induction of dopaminergic neuron differentiation from induced pluripotent stem cells reveals impaired mitophagy in PARK2 neurons.
    Suzuki S; Akamatsu W; Kisa F; Sone T; Ishikawa KI; Kuzumaki N; Katayama H; Miyawaki A; Hattori N; Okano H
    Biochem Biophys Res Commun; 2017 Jan; 483(1):88-93. PubMed ID: 28057485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation.
    Lin CH; Cheng YC; Lin HI; Ho MC; Hsu YH; Wen CH; Ko HW; Lu HE; Huang CY; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():123-127. PubMed ID: 29127874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
    Li H; Jiang H; Zhang B; Feng J
    J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.
    Xu X; Huang J; Li J; Liu L; Han C; Shen Y; Zhang G; Jiang H; Lin Z; Xiong N; Wang T
    Cell Prolif; 2016 Feb; 49(1):14-26. PubMed ID: 26748765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.
    Cheng YC; Huang CY; Ho MC; Hsu YH; Syu SH; Lu HE; Lin HI; Lin CH; Hsieh PCH
    Stem Cell Res; 2018 Apr; 28():1-5. PubMed ID: 29414410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
    Kikuchi T; Morizane A; Doi D; Magotani H; Onoe H; Hayashi T; Mizuma H; Takara S; Takahashi R; Inoue H; Morita S; Yamamoto M; Okita K; Nakagawa M; Parmar M; Takahashi J
    Nature; 2017 Aug; 548(7669):592-596. PubMed ID: 28858313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining Parkinson's disease research using induced pluripotent stem cells.
    Pu J; Jiang H; Zhang B; Feng J
    Curr Neurol Neurosci Rep; 2012 Aug; 12(4):392-8. PubMed ID: 22622410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.